Hudson Bay Capital Management LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,882,000
-40.9%
100,000
-50.0%
0.01%
-75.8%
Q4 2022$3,184,000
+11.2%
200,000
+14.3%
0.03%
+32.0%
Q3 2022$2,863,000
-27.4%
175,000
-37.5%
0.02%
-16.7%
Q2 2022$3,945,000
+715.1%
280,000
+1300.0%
0.03%
+328.6%
Q1 2022$484,000
-53.9%
20,000
-55.6%
0.01%
-36.4%
Q4 2021$1,050,000
-84.1%
45,000
-88.7%
0.01%
-87.8%
Q3 2021$6,594,000
+350.7%
397,000
+561.7%
0.09%
+400.0%
Q2 2021$1,463,000
+89.0%
60,000
+100.0%
0.02%
+80.0%
Q1 2021$774,000
-37.5%
30,0000.0%0.01%
-44.4%
Q3 2020$1,238,000
+208.7%
30,000
+100.0%
0.02%
+100.0%
Q2 2019$401,000
-0.5%
15,0000.0%0.01%
+80.0%
Q1 2019$403,000
+65.8%
15,0000.0%0.01%
+66.7%
Q4 2018$243,000
-70.7%
15,000
-62.5%
0.00%
-70.0%
Q3 2018$830,000
+35.8%
40,0000.0%0.01%
+11.1%
Q2 2018$611,000
-77.8%
40,000
-50.0%
0.01%
-75.7%
Q1 2017$2,750,00080,0000.04%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders